SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001732600-19-000001
Filing Date
2019-11-12
Accepted
2019-11-12 10:30:06
Documents
1
Period of Report
2018-02-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 20422
  Complete submission text file 0001732600-19-000001.txt   21883
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Issuer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 MADISON STREET 14TH FLOOR NEW YORK NY 10022
Business Address
Panicucci Rick (Reporting) CIK: 0001732600 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55535 | Film No.: 191206937